5-Pyrimidinecarbonitrile - CAS 40805-79-6
Catalog: |
BB024674 |
Product Name: |
5-Pyrimidinecarbonitrile |
CAS: |
40805-79-6 |
Synonyms: |
5-pyrimidinecarbonitrile; pyrimidine-5-carbonitrile |
IUPAC Name: | pyrimidine-5-carbonitrile |
Description: | 5-Pyrimidinecarbonitrile (CAS# 40805-79-6) is a compound useful in organic synthesis. |
Molecular Weight: | 105.10 |
Molecular Formula: | C5H3N3 |
Canonical SMILES: | C1=C(C=NC=N1)C#N |
InChI: | InChI=1S/C5H3N3/c6-1-5-2-7-4-8-3-5/h2-4H |
InChI Key: | XVIAPHVAGFEFFN-UHFFFAOYSA-N |
Boiling Point: | 237.641 °C at 760 mmHg |
Density: | 1.226 g/cm3 |
MDL: | MFCD00235052 |
LogP: | 0.34828 |
GHS Hazard Statement: | H302+H312+H332 (50%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021194914-A1 | Substituted oxoisoindoline compounds for the treatment of cancer | 20200323 |
WO-2021151926-A1 | Pesticidally active fused bicyclic heteroaromatic amino compounds | 20200130 |
US-2021283150-A1 | Methods for treating sars cov-2 infections | 20200127 |
WO-2021154687-A1 | Methods for treating sars cov-2 infections | 20200127 |
WO-2021148639-A1 | Pesticidally active fused bicyclic heteroaromatic compounds | 20200124 |
PMID | Publication Date | Title | Journal |
23811090 | 20130801 | Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives | European journal of medicinal chemistry |
22594255 | 20120501 | Synthesis and anti-inflammatory evaluation of new substituted 1-(3-chlorophenyl)-3-(4-methoxyphenyl)-1H-pyrazole derivatives | Acta poloniae pharmaceutica |
22220128 | 20111101 | 2-Benzyl-sulfanyl-4-pentyl-6-(phenyl-sulfan-yl)pyrimidine-5-carbonitrile | Acta crystallographica. Section E, Structure reports online |
16190753 | 20051006 | 5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinase | Journal of medicinal chemistry |
8632411 | 19960216 | Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity | Journal of medicinal chemistry |
Complexity: | 106 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 105.032697108 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 105.032697108 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 49.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Pyrimidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS